Old Bridge, NJ, United States of America

Frank P DiNinno

This inventor holds 85 USPTO granted patents, primarily in Carbapenem Antibiotics (CPC class 540302). Top assignees: Merck + Co., Inc., Merck Gmbh. Active years: 1978-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Frank P DiNinno. Retrieved from https://idiyas.com/inventor/frank-p-dininno

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 98.8

Average Co-Inventor Count = 2.4

ph-index = 19

Forward Citations = 873(Granted Patents)

Forward Citations (Not Self Cited) = 543(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Old Bride, NJ (US) (1994)
  • Old Bridge, NJ (US) (1978 - 2006)

Company Filing History:


Years Active: 1978-2006

Loading Chart...
Areas of Expertise:
Carbapenem Antibiotics
Estrogen Receptor Modulators
Antibacterial Compounds
Compositions
Methods of Treatment
Cationic Agents
2-Phenanthridinyl
Bridged Compounds
Intermediates
Halophenoxy Substituted
6-Amido Compounds
2-Biphenyl
85 patents (USPTO):Explore Patents

Title: Innovations by Frank P DiNinno: A Pioneer in Estrogen Receptor Modulators

Introduction

Frank P DiNinno, based in Old Bridge, NJ, is a prolific inventor with an impressive portfolio of 85 patents. His work primarily focuses on the development of estrogen receptor modulators, which hold significant promise for various medical applications. These innovations have the potential to influence treatments for a range of conditions associated with estrogen functioning.

Latest Patents

Frank's latest patents delve into the creation and application of compounds and derivatives that serve as estrogen receptor modulators. By acting as ligands for estrogen receptors, these compounds may provide therapeutic benefits in numerous areas, including bone health, cardiovascular disease, cognitive functioning, and cancer prevention. The applications of his inventions extend to conditions such as bone loss, osteoporosis, endometriosis, and various forms of cancer affecting the breast, uterus, and prostate.

Career Highlights

Throughout his career, Frank has demonstrated a commitment to advancing medical science through his research and innovations. He has collaborated with leading companies in the pharmaceutical industry, notably Merck & Company, Inc. and Merck GmbH, where he honed his expertise in drug development and patentable inventions.

Collaborations

During his tenure, Frank worked alongside notable colleagues, including Mark L Greenlee and Thomas N Salzmann. These collaborations have fostered an environment of innovation that has undoubtedly contributed to his success and the advancements in the field of estrogen receptor modulators.

Conclusion

Frank P DiNinno stands out as an influential figure in the realm of medical inventions. With a substantial number of patents to his name and a focus on critical health issues, he continues to pave the way for new therapies that have the potential to improve countless lives. His contributions to the field will undoubtedly have lasting effects on medical treatments and patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…